Earnings call transcript: STAAR Surgical tops revenue views in Q2 2026

STAAR Surgical reported strong Q2 2026 revenue growth of $93.5 million, surpassing analysts' estimates, while earnings per share fell short at $0.16, below the expected $0.22. The company's APAC sales grew by 189% year-over-year, while the Americas increased by 12%, and EMEA decreased by 1%, though it still showed a 12% improvement excluding the Middle East.

Despite the revenue miss, STAAR Surgical returned to profitability, with net income of $8.1 million, or $0.16 per share, compared to a loss of $16.8 million in the same quarter last year. The stock initially rose 1.88% in regular trading before falling 2.05% after hours, trading at $24.89, slightly below its 52-week high. Analysts forecast full-year 2026 EPS of $0.72, up from a trailing twelve months loss of $0.42 per share.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.